Drug Shortage Report for RABEPRAZOLE EC
Report ID | 214284 |
Drug Identification Number | 02356511 |
Brand name | RABEPRAZOLE EC |
Common or Proper name | RABEPRAZOLE SODIUM |
Company Name | SANIS HEALTH INC |
Market Status | MARKETED |
Active Ingredient(s) | RABEPRAZOLE SODIUM |
Strength(s) | 10MG |
Dosage form(s) | TABLET (ENTERIC-COATED) |
Route of administration | ORAL ORAL |
Packaging size | 100 |
ATC code | A02BC |
ATC description | DRUGS FOR PEPTIC ULCER AND GASTROESOPHAGEAL REFLUX DISEASE (GERD) |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2023-12-22 |
Estimated end date | 2024-10-04 |
Actual end date | 2024-09-30 |
Shortage status | Resolved |
Updated date | 2024-10-01 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 1 PRESIDENTS CHOICE CIRCLE BRAMPTON, ONTARIO CANADA L6Y 5S5 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v32 | 2024-10-01 | English | Compare |
v31 | 2024-09-30 | French | Compare |
v30 | 2024-09-30 | English | Compare |
v29 | 2024-09-30 | English | Compare |
v28 | 2024-09-09 | French | Compare |
v27 | 2024-09-09 | English | Compare |
v26 | 2024-08-28 | French | Compare |
v25 | 2024-08-28 | English | Compare |
v24 | 2024-07-24 | French | Compare |
v23 | 2024-07-24 | English | Compare |
v22 | 2024-05-08 | French | Compare |
v21 | 2024-05-08 | English | Compare |
v20 | 2024-05-01 | French | Compare |
v19 | 2024-05-01 | English | Compare |
v18 | 2024-04-24 | French | Compare |
v17 | 2024-04-24 | English | Compare |
v16 | 2024-04-17 | French | Compare |
v15 | 2024-04-17 | English | Compare |
v14 | 2024-04-10 | French | Compare |
v13 | 2024-04-10 | English | Compare |